Acutus Medical Inc.

0.7254-0.0146-1.97%Vol 18.65K1Y Perf -14.93%
Oct 3rd, 2023 16:00 DELAYED
BID0.7200 ASK0.7843
Open0.7600 Previous Close0.7400
Pre-Market- After-Market0.73
 - -  0.00 -0.06%
Target Price
2.00 
Analyst Rating
Hold 3.00
Potential %
175.71 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★     51.09
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     52.76
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
20.86 
Earnings Rating
Market Cap21.22M 
Earnings Date
9th Nov 2023
Alpha-0.08 Standard Deviation0.27
Beta0.88 

Today's Price Range

0.72000.7600

52W Range

0.40001.96

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
8.58%
1 Month
51.64%
3 Months
-16.85%
6 Months
-4.52%
1 Year
-14.93%
3 Years
-97.29%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AFIB0.7254-0.0146-1.97
AAPL172.40-1.3500-0.78
GOOG133.30-1.8700-1.38
MSFT313.39-8.4100-2.61
XOM115.830.20000.17
WFC38.67-0.9400-2.37
JNJ155.340.19000.12
FB196.640.99000.51
GE107.76-1.0300-0.95
JPM142.71-1.0600-0.74
Financial StrengthValueIndustryS&P 500US Markets
3.80
5.10
0.40
0.67
-15.50
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
-112.70
-512.50
-466.90
-
-
RevenueValueIndustryS&P 500US Markets
11.40M
0.40
74.90
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.61-0.63-3.28
Q01 2023-0.66-0.5713.64
Q04 2022-0.700.41158.57
Q03 2022-0.83-0.7213.25
Q02 2022-0.830.16119.28
Q01 2022-1.10-1.11-0.91
Q04 2021-0.92-1.13-22.83
Q03 2021-0.92-0.99-7.61
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date9th Nov 2023
Estimated EPS Next Report-0.57
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume18.65K
Shares Outstanding29.26K
Shares Float25.51M
Trades Count154
Dollar Volume13.63K
Avg. Volume88.54K
Avg. Weekly Volume62.83K
Avg. Monthly Volume96.79K
Avg. Quarterly Volume106.00K

Acutus Medical Inc. (NASDAQ: AFIB) stock closed at 0.74 per share at the end of the most recent trading day (a 6.23% change compared to the prior day closing price) with a volume of 95.32K shares and market capitalization of 21.22M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 291 people. Acutus Medical Inc. CEO is Vincent J. Burgess.

The one-year performance of Acutus Medical Inc. stock is -14.93%, while year-to-date (YTD) performance is -35.65%. AFIB stock has a five-year performance of %. Its 52-week range is between 0.4 and 1.96, which gives AFIB stock a 52-week price range ratio of 20.86%

Acutus Medical Inc. currently has a PE ratio of -0.40, a price-to-book (PB) ratio of 0.66, a price-to-sale (PS) ratio of 3.09, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -55.11%, a ROC of -58.86% and a ROE of -89.82%. The company’s profit margin is -%, its EBITDA margin is -466.90%, and its revenue ttm is $11.40 Million , which makes it $0.40 revenue per share.

Of the last four earnings reports from Acutus Medical Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.57 for the next earnings report. Acutus Medical Inc.’s next earnings report date is 09th Nov 2023.

The consensus rating of Wall Street analysts for Acutus Medical Inc. is Hold (3), with a target price of $2, which is +175.71% compared to the current price. The earnings rating for Acutus Medical Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Acutus Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Acutus Medical Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 18.68, ATR14 : 0.07, CCI20 : 100.57, Chaikin Money Flow : -0.03, MACD : 0.04, Money Flow Index : 74.39, ROC : 42.31, RSI : 61.93, STOCH (14,3) : 83.90, STOCH RSI : 0.95, UO : 54.22, Williams %R : -16.10), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Acutus Medical Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
3.00
Hold
3.00
Hold
3.00

Acutus Medical Inc.

Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Europe.

CEO: Vincent J. Burgess

Telephone: +1 442 232-6080

Address: 2210 Faraday Avenue, Carlsbad 92008, CA, US

Number of employees: 291

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

48%52%

Bearish Bullish

56%44%

Bearish Bullish

58%42%

 

News

Stocktwits